Diabetes

Overview

The program provides resources for clinicians as they follow evidence based clinical practice guidelines in the diagnosis and treatment of patients with Diabetes. The 2010 American Diabetes Association Clinical Practice Recommendations are used as the basis of the program. Click here for the Executive Summary of the Recommendations modified for CCNC Quality Measures and Feedback Process. One page version of the recommendation are availble for Adults and Children.

 


Patient Education

Control the ABC’s of Diabetes

Hyper-Hypo Glycemia - English | Spanish

First Steps for Health Eating - English | Spanish

Learning about Diabetes

Diabetes Self Care Goals

 

 

Referral Resources

WakeMed Adult Diabetes Medical Referral Form

WakeMed Children Diabetes and Endocrinology Center

Diabetes Umbrella Program at Johnston County Health Department- Info and Referral Form

Diabetic Teaching at Johnston Health - Contact 919-938-7534 for info - Referral Form

Diabetes bus at Benson Area Medical Center in Johnston County - Info and Referral Form 

Rex Diabetes Education Center

Duke Raleigh Hospital Diabetes Center


 

Measures

  • 1 or more measurement of HbA1c per year
  • A1c control (good) – Most recent HbA1c <8% (patients ≥ 18 yrs)
  • A1c control (poor) – Most recent HbA1c >9% or no test in past year (patients ≥ 18 yrs)
  • Lipid Management (good) – Most recent LDL-C is < 100mg/dl (patients ≥ 18 yrs)
  • Lipid Management (poor) – Most recent LDL-C is > 130 mg/dl or no test in past year (all ages)
  • BP control (good) – Most recent BP <130 systolic and <80 diastolic (patients ≥ 18 yrs)
  • BP control (poor) – Most recent BP > 140 systolic or >90 diastolic (all ages)
  • Foot exam in past year (patients ≥ 18 yrs)
  • Claim for an eye exam (patients ≥ 10 yrs)
  • Nephropathy Screen (patients ≥ 10 yrs)
  • Smoking status addressed and cessation advice given to smokers (patients ≥ 10 yrs)
  • Among patients who have been dispensed medication for hypertension and diabetes, % who are NOT receiving an ACE inhibitor or ARB